Celgene Corporation to Webcast at Upcoming Investor Conferences

  Celgene Corporation to Webcast at Upcoming Investor Conferences

BIO CEO & Investor Conference 2013 Citi Global Healthcare Conference 2013 2013
RBC Capital Markets Healthcare Conference

Business Wire

SUMMIT, N.J. -- February 4, 2013

Celgene Corporation (NASDAQ: CELG) plans to present at three upcoming investor
conferences. The conferences will be webcast live and will be available in the
Investor Relations section of the Company’s Web site at www.celgene.com.
Celgene management will provide an overview of the Company.

Monday, February 11, 2013 Celgene will present at the 15th Annual BIO CEO &
Investor Conference at 8:00 a.m. ET.

Tuesday, February 26, 2013 Celgene will present at the 2013 Citi Global
Healthcare Conference at 9:35 a.m. ET.

Wednesday, February 27, 2013 Celgene will present at the 2013 RBC Capital
Markets Healthcare Conference at 3:00 p.m. ET.

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated
global biopharmaceutical company engaged primarily in the discovery,
development and commercialization of novel therapies for the treatment of
cancer and inflammatory diseases through gene and protein regulation. For more
information, please visit the company’s Web site at www.celgene.com.

Forward-Looking Statements

This press release contains forward-looking statements, which are generally
statements that are not historical facts. Forward-looking statements can be
identified by the words "expects," "anticipates," "believes," "intends,"
"estimates," "plans," "will," “outlook” and similar expressions.
Forward-looking statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are made. We
undertake no obligation to update any forward-looking statement in light of
new information or future events, except as otherwise required by law.
Forward-looking statements involve inherent risks and uncertainties, most of
which are difficult to predict and are generally beyond our control. Actual
results or outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of factors,
many of which are discussed in more detail in our Annual Report on Form 10-K
and our other reports filed with the Securities and Exchange Commission.

Contact:

Celgene Corporation
Jacqualyn A. Fouse, Ph.D, 908-673-9956
EVP, Chief Financial Officer
or
Patrick E. Flanigan III, 908-673-9969
VP, Investor Relations
 
Press spacebar to pause and continue. Press esc to stop.